Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge

FEMS Immunology and Medical Microbiology

Volumn 41, Issue 2, 2004, Pages 93-100

  Chambers, Mark A ^a   Gavier Widén, Dolores ^b   Hewinson, R Glyn ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Antibodies; Mice; Monoclonal; Mycobacterium; Virulence

Indexed keywords

MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MBS43; MPB83 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL COUNT; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUBERCULOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BODY WEIGHT; COLONY COUNT, MICROBIAL; FEMALE; HISTOCYTOCHEMISTRY; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

EID: 2442577262     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.01.004     Document Type: Article

References (50)

1. W.H.O. (2001) Global Tuberculosis Control. WHO Report 2000. World Health Organisation, Geneva
2. Dankner W.M., Waecker N.J., Essey M.A., Moser K., Thompson M., Davis C.E. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore). 72:1993;11-37
3. O'Reilly L.M., Daborn C.J. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber. Lung Dis. 76(Suppl. 1):1995;1-46
4. Weyer K., Fourie P.B., Durrheim D., Lancaster J., Haslov K., Bryden H. Mycobacterium bovis as a zoonosis in the Kruger National Park, South Africa. Int. J. Tuberc. Lung Dis. 3:1999;1113-1119
5. O.I.E. (2001) World Animal Health - annual reports
6. Kidane D., Olobo J.O., Habte A., Negesse Y., Aseffa A., Abate G., Yassin M.A., Bereda K., Harboe M. Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR. J. Clin. Microbiol. 40:2002;4230-4234
7. Glatman-Freedman A., Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11:1998;514-532
8. Teitelbaum R., Glatman-Freedman A., Chen B., Robbins J.B., Unanue E., Casadevall A., Bloom B.R. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA. 95:1998;15688-15693
9. Menozzi F.D., Rouse J.H., Alavi M., Laude-Sharp M., Muller J., Bischoff R., Brennan M.J., Locht C. Identification of a heparin-binding hemagglutinin present in mycobacteria. J. Exp. Med. 184:1996;993-1001
10. Pethe K., Alonso S., Biet F., Delogu G., Brennan M.J., Locht C., Menozzi F.D. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature. 412:2001;190-194
11. Fifis T., Rothel J.S., Wood P.R. Soluble Mycobacterium bovis protein antigens: studies on their purification and immunological evaluation. Vet. Microbiol. 40:1994;65-81
12. Fifis T., Corner L.A., Rothel J.S., Wood P.R. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand. J. Immunol. 39:1994;267-274
13. Goodger J., Russell W.P., Nolan A., Newell D.G. Production and characterization of a monoclonal badger anti-immunoglobulin G and its use in defining the specificity of Mycobacterium bovis infection in badgers by western blot. Vet. Immunol. Immunopathol. 40:1994;243-252
14. O'Loan C., Pollock J., Hanna J., Neill S. Immunoblot analysis of humoral immune responses to Mycobacterium bovis in experimentally infected cattle: early recognition of a 26-kilodalton antigen. Clin. Diagn. Lab. Immunol. 1:1994;608-611
15. Vordermeier H.M., Cockle P.C., Whelan A., Rhodes S., Palmer N., Bakker D., Hewinson R.G. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin. Diagn. Lab. Immunol. 6:1999;675-682
16. Harboe M., Nagai S., Wiker H.G., Sletten K., Haga S. Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG. Scand. J. Immunol. 42:1995;46-51
17. Hewinson R.G., Michell S.L., Russell W.P., McAdam R.A., Jacobs W.J. Molecular characterization of MPT83: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70. Scand. J. Immunol. 43:1996;490-499
18. Wiker H.G., Nagai S., Hewinson R.G., Russell W.P., Harboe M. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand. J. Immunol. 43:1996;374-380
19. Vosloo W., Tippoo P., Hughes J.E., Harriman N., Emms M., Beatty D.W., Zappe H., Steyn L.M. Characterisation of a lipoprotein in Mycobacterium bovis (BCG) with sequence similarity to the secreted protein MPB70. Gene. 188:1997;123-128
20. Harboe M., Wiker H.G., Ulvund G., Lund-Pedersen B., Andersen A.B., Hewinson R.G., Nagai S. MPB70 and MPB83 as indicators of protein localization in mycobacterial cells. Infect. Immun. 66:1998;289-296
21. Chambers M.A., Vordermeier H., Whelan A., Commander N., Tascon R., Lowrie D., Hewinson R.G. Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83. Clin. Infect. Dis. 30(Suppl. 3):2000;S283-S287
22. Chambers M.A., Stagg D., Gavier-Widen D., Lowrie D., Newell D., Hewinson R.G. A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles). Res. Vet. Sci. 71:2001;119-126
23. Chambers M.A., Williams A., Hatch G., Gavier-Widen D., Hall G., Huygen K., Lowrie D., Marsh P.D., Hewinson R.G. Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis. Infect. Immun. 70:2002;2159-2165
24. Garnier T., Eiglmeier K., Camus J.C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B., Atkin R., Doggett J., Mayes R., Keating L., Wheeler P.R., Parkhill J., Barrell B.G., Cole S.T., Gordon S.V., Hewinson R.G. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. USA. 100:2003;7877-7882
25. Goodger J., Nolan A., Russell W.P., Dalley D.J., Thorns C.J., Stuart F.A., Croston P., Newell D.G. Serodiagnosis of Mycobacterium bovis infection in badgers: development of an indirect ELISA using a 25 kDa antigen. Vet. Rec. 135:1994;82-85
26. Casadevall A. Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6:1998;102-107
27. Hill L.E. Hypogammaglobulinaemia in the United Kingdom. 3. Clinical features of hypogammaglobulinaemia. Spec. Rep. Ser. Med. Res. Counc. (G. B.). 310:1971;9-34
28. Anonymous (1969) Hypogammaglobulinaemia in the United Kingdom. Summary report of a Medical Research Council working-party. Lancet 1, 163-168
29. Glatman-Freedman A., Mednick A.J., Lendvai N., Casadevall A. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infect. Immun. 68:2000;335-341
30. Bruyn G.A., Zegers B.J., van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin. Infect. Dis. 14:1992;251-262
31. Plommet M., Plommet A.M. Immune serum-mediated effects on brucellosis evolution in mice. Infect. Immun. 41:1983;97-105
32. Winter A.J., Duncan J.R., Santisteban C.G., Douglas J.T., Adams L.G. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect. Immun. 57:1989;3438-3444
33. Orme I.M., Collins F.M. Mouse model of tuberculosis. Bloom B.R. Tuberculosis: Pathogenesis, Protection, and Control. 1994;113-134 ASM Press, Washington, DC
34. Dunn P.L., North R.J. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:1995;3428-3437
35. Coughlan S., Harkiss G.D., Hopkins J. Enhanced proliferation of CD4+ T cells induced by dendritic cells following antigen uptake in the presence of specific antibody. Vet. Immunol. Immunopathol. 49:1996;321-330
36. Hussain R., Shiratsuchi H., Ellner J.J., Wallis R.S. PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin. Exp. Immunol. 119:2000;449-455
37. Hussain R., Shiratsuchi H., Phillips M., Ellner J., Wallis R.S. Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin. Exp. Immunol. 123:2001;210-218
38. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., Bloom B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:1995;561-572
39. Bean A.G., Roach D.R., Briscoe H., France M.P., Korner H., Sedgwick J.D., Britton W.J. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:1999;3504-3511
40. Ehlers S., Benini J., Kutsch S., Endres R., Rietschel E.T., Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 67:1999;3571-3579
41. Amsden A.F., Boros D.L. Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity. Am. J. Pathol. 96:1979;457-476
42. Hora K., Satriano J.A., Santiago A., Mori T., Stanley E.R., Shan Z., Schlondorff D. Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc. Natl. Acad. Sci. USA. 89:1992;1745-1749
43. Peters W., Scott H.M., Chambers H.F., Flynn J.L., Charo I.F., Ernst J.D. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 98:2001;7958-7963
44. Scott H.M., Flynn J.L. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70:2002;5946-5954
45. Kipnis A., Basaraba R.J., Orme I.M., Cooper A.M. Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology. 109:2003;547-551
46. Jagannath C., Hoffmann H., Sepulveda E., Actor J.K., Wetsel R.A., Hunter R.L. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol. 52:2000;369-379
47. Actor J.K., Breij E., Wetsel R.A., Hoffmann H., Hunter R.L. Jr., Jagannath C. A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand. J. Immunol. 53:2001;464-474
48. Lin R.H., Stockinger B. Purification of the fifth component of murine complement from ascites fluid. J. Immunol. Methods. 115:1988;127-131
49. Carr M.D., Bloemink M.J., Dentten E., Whelan A.O., Gordon S.V., Kelly G., Frenkiel T.A., Hewinson R.G., Williamson R.A. Solution structure of the Mycobacterium tuberculosis complex protein MPB70: from tuberculosis pathogenesis to inherited human corneal disease. J. Biol. Chem. 278:2003;43736-43743
50. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA. 100:2003;5437-5442